African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 13, No. 2, February 2026 | pp. 85–91

DOI: 10.46882/AJIDR/148923

Article Type: Research Article

Title: Molecular epidemiology and antifungal susceptibility of Nakaseomyces glabratus isolated from recurrent vulvovaginal candidiasis patients

Names of Authors: Sipho Ndlovu¹*, Lukas Fischer², Camila Ortega³

Authors’ Affiliations: ¹Department of Obstetrics and Gynecology, University of the Witwatersrand, Johannesburg, South Africa. ²Institute of Medical Mycology, University of Cologne, Cologne, Germany. ³Department of Microbiology, University of Antioquia, Medellín, Colombia.

Abstract: Non-albicans yeast species such as Nakaseomyces glabratus (formerly Candida glabrata) increasingly drive recurrent vulvovaginal candidiasis refractory to standard azole therapy. We determined yeast species distribution, ERG11 and PDR1 resistance mutations, and antifungal susceptibility among women with recurrent symptoms. High vaginal swabs from 360 outpatients were cultured on chromogenic agar and analyzed via internal transcribed spacer sequencing and broth microdilution. Candida albicans accounted for 58.3 percent and N. glabratus for 27.5 percent of isolates, with fluconazole resistance observed in 31.3 percent of N. glabratus strains. Boric acid and nystatin ovules retained strong efficacy.

Keywords: Nakaseomyces glabratus, Vulvovaginal candidiasis, Fluconazole resistance, Antifungal susceptibility, Medical mycology

Citation: Ndlovu S, Fischer L, Ortega C (2026). Molecular epidemiology and antifungal susceptibility of Nakaseomyces glabratus isolated from recurrent vulvovaginal candidiasis patients. African Journal of Infectious Diseases Research, 13(2): 85–91. DOI: 10.46882/AJIDR/148923

Manuscript Timeline: Received: December 18, 2025; Revised: January 20, 2026; Accepted: February 02, 2026; Published: February 08, 2026